Peter Rossing, Head of Research, explains the ambition of the Biomedical Research.
Research at Steno
The research ambition is to take the lead in translational diabetes research with focus on early disease and prevention.
The research area is divided into Biomedical Research and Health Promotion Research.
Biomedical Research aims to apply knowledge and findings from research in the clinic to improve outcomes for patients with type 1 and type 2 diabetes.
The Biomedical Research is organised in these groups:
- Diabetes Complication Research: Understanding the prevention and treatment of diabetic micro- and microvascular complications of diabetes.
- Clinical Epidemiology: Developing preventive strategies for persons with reduced glucose metabolism and early treatment strategies for persons with type 2 diabetes.
- Systems Medicine: System-level understanding of metabolism and translation of this knowledge into novel solutions to benefit human health.
Health Promotion Research aims at establishing cross-disciplinary cooperation with partners at Steno as well as with external institutions in Denmark and abroad. The focus is on research with the potential to promote health in real life settings and practices.
Health Promotion Research is focusing on two areas:
- Diabetes Management Research: The focus is to develop and document innovative methods in patient education, social support of patients, and support related to ‘diabetes and the workplace’
- Diabetes Prevention Research: The focus is to identify ways to prevent diabetes in real-life settings among children and adolescents and among adults at risk.
The Metabolomics Laboratory develops and applies innovative metabolomics methodologies in order to identify and characterize the metabolic profiles and biomarkers in different human pathologies. Secondly the laboratory also develops analytical methods to translate the key findings into the clinic.
Sidst opdateret 02-01-2017
Bjarne Bruun Jensen, Head of Health Promotion Research, explains the research ambition.